T cell interactions in active rheumatoid arthritis: insights from the human autologous mixed lymphocyte reaction as a model of T cell activation cascade

SUMMARY The autologous mixed lymphocyte reaction (AMLR) represents the activation, proliferation and differentiation of T cells in response to signals from autologous non‐T cells. Using monoclonal anti‐Leu8 antibody to isolate subpopulations of human CD4+ and CD8+ T cells, we have investigated the r...

Full description

Saved in:
Bibliographic Details
Published inClinical and experimental immunology Vol. 85; no. 1; pp. 55 - 60
Main Authors SAKANE, T., MURAKAWA, Y., TAKENO, M., SHIGEKI, T., NAGAFUCHI, H., MIKI, T.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.07.1991
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:SUMMARY The autologous mixed lymphocyte reaction (AMLR) represents the activation, proliferation and differentiation of T cells in response to signals from autologous non‐T cells. Using monoclonal anti‐Leu8 antibody to isolate subpopulations of human CD4+ and CD8+ T cells, we have investigated the role of these subpopulations in the T cell activation cascade during the course of AMLR. In normal subjects, CD4+ Leu8+ cells are necessary for the initiation of the AMLR response, and sequentially lead to activation and proliferation of both CD4+ Leu8‐ cells and CD8+ Lcu8+ cells. The activated CD8+Lcu8+ cells, in turn, induce CD8+ Leu8‐ cells to generate proliferation of the latter cells. Soluble mediators could be involved in the T cell activation cascade induced by the AMLR. Patients with active rheumatoid arthritis have a profound defect in the AMLR. Further analysis indicates that rheumatoid arthritis CD8+ T cells are markedly defective as responding cells in the AMLR. The impaired AMLR response by CD8+ cells cannot be reconstituted with AMLR‐derived supernatants from normal T cells. The data suggest that the defective CD8+ T cell function may contribute to the pathogenesis of the disease.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0009-9104
1365-2249
DOI:10.1111/j.1365-2249.1991.tb05681.x